Back
CRISPR Therapeutics AG Stock Price Chart
This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
CRSP
CRISPR Therapeutics AG
Last Price:
$38.28
Seasonality Move:
20.1%
7 Day Trial
ALL ACCESS PASS
$
7
Major Market Shift - Act Now Before it's Too Late
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is moderately bullish and CRSP is experiencing slight selling pressure.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.43 | Sell |
| 20-day SMA: | 36.1 | Buy |
| 50-day SMA: | 40.71 | Sell |
| 200-day SMA: | 45.82 | Sell |
| 8-day EMA: | 38.12 | Buy |
| 20-day EMA: | 34.63 | Buy |
| 50-day EMA: | 24.01 | Buy |
| 200-day EMA: | 8.5 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.07 | Buy |
| Relative Strength Index (14 RSI): | 50.42 | Buy |
| Chaikin Money Flow: | -525417 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9 - 40.02) | Buy |
| Bollinger Bands (100): | (37.22 - 46.82) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 38.27 while CRSP 8-day simple moving average is 38.43, which is a Sell signal.
-
The stock price of CRSP is 38.27 while CRISPR Therapeutics AG 20-day SMA is 36.10, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 40.71 while CRSP share price is 38.27, making it a Sell technically.
-
CRSP stock price is 38.27 and CRISPR Therapeutics AG 200-day simple moving average is 45.82, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
34
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $38.27. The Score for CRSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.3B
Price in USD:
38.27
Share Volume:
1.3M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
67.88
52-Week Low:
30.04
Sell
34
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 38.27 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 38.27 while CRSP 8-day exponential moving average is 38.12, which is a Buy signal.
-
The stock price of CRSP is 38.27 while CRISPR Therapeutics AG 20-day EMA is 34.63, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 24.01 while CRSP share price is 38.27, making it a Buy technically.
-
CRSP stock price is 38.27 and CRISPR Therapeutics AG 200-day simple moving average is 8.50, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.94 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is 5.07, suggesting CRISPR Therapeutics AG is a Buy
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 50.42, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (33.9 - 40.02), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (37.22 - 46.82), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.